NigeriaTaevas Global helps medical devices manufacturers navigate NAFDAC product registration requirements and achieve compliant, accelerated market entry into Nigeria — Africa's largest healthcare economy.
Our end-to-end registration framework covers every dimension a medical devices company needs to enter Nigeria with confidence and regulatory certainty.
We map your device classification under the NAFDAC Medical Devices and Diagnostics Regulations to identify the correct registration pathway before a single document is prepared. This prevents costly reclassification delays and ensures your submission is routed correctly from day one. Our team benchmarks your device against comparable approved products to set realistic timelines.
Our four-phase engagement takes you from initial scoping through to a fully lodged, actively managed NAFDAC submission with clear milestones at every stage.
We conduct a structured intake session to understand your device portfolio, existing regulatory approvals in other markets, current technical documentation status, and commercial timeline. This scoping exercise allows us to define the exact registration pathway, identify documentation gaps, and produce a project plan with realistic milestones. You receive a written scope of work and fixed-fee proposal before any work begins.
The discovery phase includes a device classification pre-check against NAFDAC's current device register, a review of any existing CE marking or FDA clearance documentation you hold, and an initial risk assessment of your dossier readiness. We also confirm whether your target product categories require mandatory product testing at NAFDAC-accredited laboratories in Nigeria, which affects timeline planning significantly.
Nigeria imports an estimated 70 to 80 percent of its medical devices, creating significant and sustained demand for foreign manufacturers seeking registration and market entry. Local manufacturing capacity remains limited, concentrated primarily in consumables and basic equipment, which means registered imported devices face relatively low domestic competition. This structural dependency makes regulatory access — via NAFDAC registration — the primary barrier and competitive differentiator for foreign manufacturers.
NAFDAC has been progressively modernising its medical devices regulatory framework, including the introduction of online submission portals and alignment with ECOWAS harmonised medical devices regulations. The agency has also introduced a risk-based classification system broadly aligned with the Global Harmonization Task Force framework, making it easier for manufacturers with existing CE marking or US FDA clearance to leverage prior approvals. However, local labelling requirements and the mandatory local agent requirement remain Nigeria-specific obligations that require careful management.
Federal and state government health institutions, including university teaching hospitals, federal medical centres, and state specialist hospitals, represent the dominant procurement channel for medical devices in Nigeria. The National Health Insurance Authority is expanding coverage, which is expected to increase formalised procurement volumes over the medium term. Manufacturers with NAFDAC registration are eligible to participate in government tenders, which are often the most significant commercial opportunity in the market.
Diagnostic imaging equipment, in-vitro diagnostics, and point-of-care testing devices are among the fastest-growing segments in the Nigerian medical devices market, driven by increased investment in hospital infrastructure and a rising burden of non-communicable diseases. The COVID-19 pandemic accelerated adoption of rapid diagnostic tests and highlighted significant gaps in diagnostic capacity that are now being addressed through both public and private investment. Manufacturers in these categories face strong market pull alongside rigorous NAFDAC review requirements for IVDs.
Every Taevas Global Product Registration engagement for Nigeria delivers a structured set of outputs designed to take your medical device from dossier preparation to NAFDAC approval and commercial readiness.
A written assessment of your device classification, applicable NAFDAC registration pathway, required documentation, estimated timeline, and fee schedule — delivered before engagement commencement.
A fully compiled, quality-reviewed registration dossier including all administrative, technical, and clinical documentation formatted to NAFDAC requirements and ready for submission.
A detailed gap analysis identifying missing or non-compliant documents in your existing technical file, with a prioritised remediation plan and owner assignments.
A standards compliance matrix mapping your device against applicable ISO, IEC, and NAFDAC standards, with evidence references and any outstanding compliance actions identified.
Identification and vetting of qualified Nigerian local agents, plus drafting and review of the authorisation agreement required by NAFDAC for foreign manufacturers.
End-to-end submission lodgement, status tracking, and management of all NAFDAC queries and requests for additional information through to final approval decision.
The original NAFDAC registration certificate and registration number, delivered with a certified copy of the approved dossier and all submission correspondence.
A handover document covering renewal timelines, variation trigger guide, post-market surveillance obligations, and recommended next steps for commercial market access in Nigeria.
Your medical device is approved in the EU, US, or another regulated market and you are entering Nigeria for the first time. You need to understand NAFDAC's requirements, appoint a local agent, and navigate a regulatory process that is materially different from what your internal team has handled before. Speed to market matters because you have distributor commitments or a tender opportunity with a defined deadline.
Taevas Global combines in-country NAFDAC expertise with deep medical devices regulatory knowledge to get your product registered and commercially active in Nigeria's healthcare market. Let us manage the complexity so you can focus on growth.